First Berlin – Formycon AG Research Update (22.06.2026)
First Berlin Equity Research hat ein Research Update zu Formycon AG (ISIN: DE000A1EWVY8) veröffentlicht. Analyst Simon Scholes bestätigt seine BUY-Empfehlung [...]
First Berlin – Formycon AG Research Update (22/06/2026)
First Berlin Equity Research has published a research update on Formycon AG (ISIN: DE000A1EWVY8). Analyst Simon Scholes reiterated his BUY [...]
First Berlin – LAIQON AG Research Update (15.06.2026)
First Berlin Equity Research hat ein Research Update zu LAIQON AG (ISIN: DE000A12UP29) veröffentlicht. Analyst Christian Orquera bestätigt seine BUY-Empfehlung [...]
First Berlin – LAIQON AG Research Update (15/06/2026)
First Berlin Equity Research has published a research update on LAIQON AG (ISIN: DE000A12UP29). Analyst Christian Orquera reiterated his BUY [...]
First Berlin – DN Group AG Research Update (12.06.2026)
First Berlin Equity Research hat am 12.06.2026 die Coverage der DN Group AG (ISIN: DE000A3DW408) aufgenommen. Analyst Alexander Rihane stuft [...]
First Berlin – DN Group AG Research Update (12/06/2026)
First Berlin Equity Research on 12/06/2026 initiated coverage on DN Group AG (ISIN: DE000A3DW408). Analyst Alexander Rihane placed an ADD [...]
First Berlin – MaaT Pharma SACA Research Update (11.06.2026)
First Berlin Equity Research hat ein Research Update zu MaaT Pharma SACA (ISIN: FR0012634822) veröffentlicht. Analyst Christian Orquera ändert seine [...]
First Berlin – MaaT Pharma SACA Research Update (11/06/2026)
First Berlin Equity Research has published a research update on MaaT Pharma SACA (ISIN: FR0012634822). Analyst Christian Orquera changed his [...]
First Berlin – LAIQON AG Research Update (08/06/2026)
First Berlin Equity Research has published a research update on LAIQON AG (ISIN: DE000A12UP29). Analyst Christian Orquera reiterated his BUY [...]
First Berlin – LAIQON AG Research Update (08.06.2026)
First Berlin Equity Research hat ein Research Update zu LAIQON AG (ISIN: DE000A12UP29) veröffentlicht. Analyst Christian Orquera bestätigt seine BUY-Empfehlung [...]
Didn’t find what you’re looking for?
If you have unanswered questions about our services and are classified as an institutional investor, contact us to see how we can service your institution.

Stay In Touch